ANTIBIOTIC SELECTION FACTORS AND DESCRIPTION OF A HOSPITAL-BASED OUTPATIENT ANTIBIOTIC-THERAPY PROGRAM IN THE USA

被引:48
作者
CRAIG, WA [1 ]
机构
[1] UNIV WISCONSIN,MADISON,WI 53705
关键词
D O I
10.1007/BF01690745
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
A variety of pharmacodynamic, pharmacokinetic and drug stability factors can influence the choice of drug, the dosing regimen and the method of drug administration for outpatient parenteral antibiotic therapy (OPAT). Beta-lactam antibiotics exhibit little if any concentration-dependent killing and produce short-term or no persistent effects with most bacterial pathogens. Optimal dosing regimens for these agents should provide serum levels that continually exceed the minimal inhibitory concentration (MIC) of the pathogen. Beta-lactam agents with long half-lives (greater than 2 hours) can provide these levels with intermittent dosing once or twice daily. Beta-lactam agents with shorter half-lives can be administered by programmable pumps or by continuous infusion providing the drug is sufficiently stable to degradation in solution. Imipenem and ampicillin are examples of drugs with short half-lives that are unstable in solution and must be dosed intermittently. Intramuscular administration slows absorption and can also prolong the length of time during which serum levels exceed the MIC of infecting bacteria. Aminoglycosides and fluoroquinolones, on the other hand, exhibit concentration-dependent killing and produce prolonged persistent effects. Optimal dosage regimens of these drugs should maximize serum levels. Once-daily dosing regimens for the aminoglycosides meet this goal and also appear to reduce drug-induced nephrotoxicity. Application of these principles to drug selection and administration in a hospital-based OPAT program has provided efficacious therapy and a low incidence of adverse reactions in an elderly population distributed over a wide geographic area.
引用
收藏
页码:636 / 642
页数:7
相关论文
共 27 条
[1]   COMPARATIVE-STUDY WITH ENOXACIN AND NETILMICIN IN A PHARMACODYNAMIC MODEL TO DETERMINE IMPORTANCE OF RATIO OF ANTIBIOTIC PEAK CONCENTRATION TO MIC FOR BACTERICIDAL ACTIVITY AND EMERGENCE OF RESISTANCE [J].
BLASER, J ;
STONE, BB ;
GRONER, MC ;
ZINNER, SH .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1987, 31 (07) :1054-1060
[2]  
Craig W A, 1990, Scand J Infect Dis Suppl, V74, P63
[3]   SELECTING THE ANTIBIOTIC [J].
CRAIG, WA .
HOSPITAL PRACTICE, 1993, 28 :16-20
[4]   POSTANTIBIOTIC EFFECTS IN EXPERIMENTAL-INFECTION MODELS - RELATIONSHIP TO INVITRO PHENOMENA AND TO TREATMENT OF INFECTIONS IN MAN [J].
CRAIG, WA .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1993, 31 :149-158
[5]   PHARMACODYNAMICS OF AMIKACIN INVITRO AND IN MOUSE THIGH AND LUNG INFECTIONS [J].
CRAIG, WA ;
REDINGTON, J ;
EBERT, SC .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1991, 27 :29-40
[6]   CONTINUOUS INFUSION OF BETA-LACTAM ANTIBIOTICS [J].
CRAIG, WA ;
EBERT, SC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (12) :2577-2583
[7]  
CRAIG WA, 1994, CAN J INFECT DIS SC, P28
[8]   INFLUENCE OF DOSAGE SCHEDULE ON RENAL CORTICAL ACCUMULATION OF AMIKACIN AND TOBRAMYCIN IN MAN [J].
DEBROE, ME ;
VERBIST, L ;
VERPOOTEN, GA .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1991, 27 :41-47
[9]   PHARMACODYNAMICS OF INTRAVENOUS CIPROFLOXACIN IN SERIOUSLY ILL-PATIENTS [J].
FORREST, A ;
NIX, DE ;
BALLOW, CH ;
GOSS, TF ;
BIRMINGHAM, MC ;
SCHENTAG, JJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (05) :1073-1081
[10]   ANTIMICROBIAL SUSCEPTIBILITY CHANGES IN ENTEROCOCCUS-FAECALIS FOLLOWING VARIOUS PENICILLIN EXPOSURE REGIMENS [J].
HODGES, TL ;
ZIGHELBOIMDAUM, S ;
ELIOPOULOS, GM ;
WENNERSTEN, C ;
MOELLERING, RC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (01) :121-125